Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Subarna Chakravorty

Subarna Chakravorty

MBBS, MRCPCH, FRCPath, PhD
King’s College Hospital NHS Trust
Acute chest syndrome in sickle cell disease: pathophysiology, management, and prevention 4:49
Acute chest syndrome in sickle cell disease: pathophysiology, management, and prevention
Subarna Chakravorty • 3 Nov 2025
The role of inflammation in SCD pathophysiology and potential avenues for targeting it 6:48
The role of inflammation in SCD pathophysiology and potential avenues for targeting it
Subarna Chakravorty • 3 Nov 2025
Transplantation and gene therapy in SCD and thalassemia: donor types and indications 10:55
Transplantation and gene therapy in SCD and thalassemia: donor types and indications
Subarna Chakravorty • 3 Nov 2025
Should MRI brain assessment be routinely performed in all patients with sickle cell disease? 5:05
Should MRI brain assessment be routinely performed in all patients with sickle cell disease?
Subarna Chakravorty • 3 Nov 2025
Musculoskeletal complications of SCD: distinguishing between vaso-occlusive events & osteomyelitis 2:06
Musculoskeletal complications of SCD: distinguishing between vaso-occlusive events & osteomyelitis
Subarna Chakravorty • 2 Oct 2024
The promise of pyruvate kinase activators, such as mitapivat, for treating SCD and thalassemia 2:48
The promise of pyruvate kinase activators, such as mitapivat, for treating SCD and thalassemia
Subarna Chakravorty • 2 Oct 2024
Introducing the Universal Care Plan for patients with sickle cell disease in London 4:28
Introducing the Universal Care Plan for patients with sickle cell disease in London
Subarna Chakravorty • 2 Oct 2024
The recent withdrawal of voxelotor from the market: the potential impact on patients with SCD 3:02
The recent withdrawal of voxelotor from the market: the potential impact on patients with SCD
Subarna Chakravorty • 2 Oct 2024
A global view of the challenges and unmet needs that remain in treating pediatric patients with SCD 1:52
A global view of the challenges and unmet needs that remain in treating pediatric patients with SCD
Subarna Chakravorty • 16 Jun 2024
Challenges associated with gene therapies for SCD and thalassemia 2:08
Challenges associated with gene therapies for SCD and thalassemia
Subarna Chakravorty • 16 Jun 2024
The patient burden of illness and unmet needs in SCD & highlights from EHA 2024 3:49
The patient burden of illness and unmet needs in SCD & highlights from EHA 2024
Subarna Chakravorty • 16 Jun 2024
Global initiatives in SCD and the role of the Lancet Commission 2:57
Global initiatives in SCD and the role of the Lancet Commission
Subarna Chakravorty • 26 Oct 2023
Overcoming the financial challenge of gene therapy for SCD 1:17
Overcoming the financial challenge of gene therapy for SCD
Subarna Chakravorty • 26 Oct 2023
Disease-modifying and curative SCD treatment updates from ASCAT 2023 5:16
Disease-modifying and curative SCD treatment updates from ASCAT 2023
Subarna Chakravorty • 26 Oct 2023
The current landscape of thalassemia treatment 2:23
The current landscape of thalassemia treatment
Subarna Chakravorty • 26 Oct 2023
Session highlights: top abstracts in red cell disorders 3:04
Session highlights: top abstracts in red cell disorders
Subarna Chakravorty • 24 Apr 2023
The content of VJHemOnc is intended for healthcare professionals